Valeria Grancini - Concepedia

Author

Valeria Grancini

University of Milan ORCID

Also Known As

E. Orsi, Elena Lunati, GRANCINI, VALERIA, Grancini, Valeria, V. Grancini, VALERIA GRANCINI, Valeria Grancini

Publications

628

Citations

H-Index

Concepts

All Affiliations

University of Milan Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico University of Verona University of Parma Istituti di Ricovero e Cura a Carattere Scientifico

About

Valeria Grancini is an author at University of Milan specializing in diabetes, medicine, and hepatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	175
2	Diabetes	5	5	175
3	Hepatology	4	4	156
4	Health Sciences	2	2	87
5	Immunology	1	1	21

Valeria Grancini

Publications

331

Citations

H-Index

Page 1

	Year	Citations
Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C Alessio Aghemo, Gian Maria Prati, Maria Grazia Rumi, Hepatology	2012	93
Contribution of β-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease Valeria Grancini, Maddalena Trombetta, Maria Elena Lunati, Journal of Hepatology Insulin ResistanceMetabolic SyndromeHepatologyLiver PhysiologyPhysiology	2015	72
Effects of first- and second-generation tyrosine kinase inhibitor therapy on glucose and lipid metabolism in chronic myeloid leukemia patients: a real clinical problem? Alessandra Iurlo, Emanuela Orsi, Daniele Cattaneo, Oncotarget	2015	63
Metabolic syndrome after liver transplantation: Short-term prevalence and pre- and post-operative risk factors Maria Elena Lunati, Valeria Grancini, F. Agnelli, Digestive and Liver Disease ObesityTransplantation SurgeryMetabolic SyndromeHepatologyMetabolic Disorder	2013	48
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients Valeria Grancini, Maddalena Trombetta, Maria Elena Lunati, Journal of Hepatology Central RoleCirrhotic PatientsHepatologySolid Organ TransplantationLiver Physiology	2019	21
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes Valeria Grancini, Andrea Gramegna, Laura Zazzeron, Diabetes & Metabolism Diabetes ManagementBody CompositionDiabetesDiabetes MellitusInsulin Delivery	2023	19
Evolution of liver fibrosis in diabetic patients with NAFLD in a follow-up study: Hepatoprotective effects of sodium-glucose co-transporter-2 inhibitors Rosa Lombardi, Alessandro Mantovani, Annalisa Cespiati, Digestive and Liver Disease Liver FibrosisPathologyFatty Liver DiseaseMetabolic SyndromeFollow-up Study	2023	15

Page 1